KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.25%.

  • Pfizer's Return on Invested Capital rose 2500.0% to 0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year increase of 2500.0%. This contributed to the annual value of 0.2% for FY2024, which is 300.0% down from last year.
  • Per Pfizer's latest filing, its Return on Invested Capital stood at 0.25% for Q3 2025, which was up 2500.0% from 0.2% recorded in Q2 2025.
  • Pfizer's Return on Invested Capital's 5-year high stood at 0.72% during Q4 2022, with a 5-year trough of 0.64% in Q4 2023.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.21% (2021), whereas its average is 0.16%.
  • Per our database at Business Quant, Pfizer's Return on Invested Capital soared by 4100bps in 2021 and then crashed by -7700bps in 2023.
  • Over the past 5 years, Pfizer's Return on Invested Capital (Quarter) stood at 0.41% in 2021, then skyrocketed by 76bps to 0.72% in 2022, then crashed by -189bps to 0.64% in 2023, then skyrocketed by 100bps to 0.0% in 2024, then soared by 27417bps to 0.25% in 2025.
  • Its Return on Invested Capital was 0.25% in Q3 2025, compared to 0.2% in Q2 2025 and 0.21% in Q1 2025.